Dra. Heather Pemberton

La Dra. Heather Pemberton es una cardióloga no invasiva dedicada al Centro de Atención Cardiovascular del Texas Heart Institute con un interés especial en la enfermedad cardíaca valvular, la prevención primaria y secundaria de la enfermedad de la arteria coronaria, el síndrome cardiometabólico, la insuficiencia cardíaca y la salud cardiovascular de la mujer.

Certificado por la Junta en Medicina Cardiovascular, Medicina Interna y Ecocardiografía, el Dr. Pemberton se destaca en la realización de ecocardiogramas transesofágicos y transtorácicos, cardioversiones de corriente continua, PET y SPECT cardíacos y pruebas de esfuerzo en cinta rodante.

Mostrar biografía completa

El Dr. Pemberton es un apasionado de la medicina preventiva, la salud cardiometabólica y el cuidado del corazón durante y después del embarazo y tiene una experiencia significativa trabajando con colegas y pacientes de obstetricia y ginecología para brindar atención cardíaca durante el embarazo, incluida la hipertensión gestacional y la preeclampsia.

Además de su trabajo clínico, la Dra. Pemberton desarrolla y participa en programas de extensión comunitaria centrados en promover una dieta saludable, el ejercicio y establecer estrategias individualizadas de estilo de vida saludable. También dedica su tiempo a educar a futuros médicos como preceptora de cardiología para residentes de medicina interna y familiar y en el Programa de Capacitación en Enfermedades Cardiovasculares del Texas Heart Institute en el Baylor St. Luke's Medical Center.

Antes de unirse al Centro de Atención Cardiovascular del Texas Heart Institute, trabajó en Carolina del Norte en el Centro Médico Cone Health, donde fue cofundadora de la Clínica de Cardio-Obstetricia y copresidenta del Simposio Anual sobre el Corazón de la Mujer.
La Dra. Pemberton obtuvo su Doctorado en Medicina en la Facultad de Medicina de la Universidad de Georgetown y completó su residencia en Medicina Interna en el Centro Médico Beth Israel Deaconess de la Facultad de Medicina de Harvard. Luego realizó una beca de investigación en Cardiología General en el Texas Heart Institute, donde se desempeñó como becaria de investigación en Cardiología. La Dra. Pemberton también adquirió experiencia en investigación como científica e ingeniera investigadora en la Universidad de Washington, donde se centró en estudiar el impacto de los inhibidores de la histona desacetilasa y el trasplante de células madre en las lesiones isquémicas en modelos animales.

A lo largo de su carrera, la Dra. Pemberton ha recibido numerosos premios y honores, entre ellos, el premio de la sesión de pósteres en la reunión científica anual del Massachusetts American College of Physicians y el prestigioso premio Milton Corn, MD de la Facultad de Medicina de la Universidad de Georgetown. Es miembro de la Sociedad de Honor Junior Alpha Omega Alpha y se graduó con honores en la Universidad de Washington.

Con su experiencia, compasión y compromiso con la excelencia, la Dra. Heather Pemberton es un miembro valioso de la comunidad de atención médica cardiovascular en el corazón del Centro Médico de Texas.

Llame Para Una Cita

Ver Publicaciones

Posiciones del Instituto del Corazón de Texas

Intereses

Educación

  • De licenciatura:

    Universidad de Washington

  • Escuela de Medicina:

    Facultad de medicina de la Universidad de Georgetown

  • Prácticas:

    Centro Médico Beth Israel Deaconess, Facultad de Medicina de Harvard

  • Residencia:

    Centro Médico Beth Israel Deaconess, Facultad de Medicina de Harvard

  • Becas:

    El Instituto del Corazón de Texas en el Centro Médico Baylor St. Luke

Afiliaciones académicas y clínicas

Certificaciones

  • Certificado por la Junta, Enfermedades Cardiovasculares
  • Certificado por la Junta, Ecocardiografía
  • Certificado por la Junta, Medicina Interna

Honores, premios y membresías

  • Cum Laude, Universidad de Washington
  • Sociedad de Honor Alpha Omega Alpha Junior
  • Premio Milton Corn, MD

Publicaciones

4862227 P39XB6TU 1 alternativas-a-la-experimentación-con-animales 10 datos desc Pemberton 61461 https://www.texasheart.org/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3Afalse%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22Y6G2BFE6%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Carroll%20et%20al.%22%2C%22parsedDate%22%3A%222017-10-15%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BCarroll%2C%20B.%20J.%2C%20%26lt%3Bstrong%26gt%3BPemberton%26lt%3B%5C%2Fstrong%26gt%3B%2C%20H.%2C%20Bauer%2C%20K.%20A.%20et%20al.%20%282017%29.%20Initiation%20of%20a%20Multidisciplinary%2C%20Rapid%20Response%20Team%20to%20Massive%20and%20Submassive%20Pulmonary%20Embolism.%20%26lt%3Bi%26gt%3BAm%20J%20Cardiol%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B120%26lt%3B%5C%2Fi%26gt%3B%2C%201393%26%23x2013%3B1398.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.amjcard.2017.07.033%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.amjcard.2017.07.033%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Initiation%20of%20a%20Multidisciplinary%2C%20Rapid%20Response%20Team%20to%20Massive%20and%20Submassive%20Pulmonary%20Embolism%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Brett%20J.%22%2C%22lastName%22%3A%22Carroll%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Heather%22%2C%22lastName%22%3A%22Pemberton%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kenneth%20A.%22%2C%22lastName%22%3A%22Bauer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Louis%20M.%22%2C%22lastName%22%3A%22Chu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jeffrey%20L.%22%2C%22lastName%22%3A%22Weinstein%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Barbara%20L.%22%2C%22lastName%22%3A%22Levarge%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Duane%20S.%22%2C%22lastName%22%3A%22Pinto%22%7D%5D%2C%22abstractNote%22%3A%22Pulmonary%20embolism%20%28PE%29%20can%20result%20in%20rapid%20clinical%20decompensation%20in%20many%20patients.%20With%20increasing%20patient%20complexity%20and%20advanced%20treatment%20options%20for%20PE%2C%20multidisciplinary%2C%20rapid%20response%20teams%20can%20optimize%20risk%20stratification%20and%20expedite%20management%20strategies.%20The%20Massive%20And%20Submassive%20Clot%20On-call%20Team%20%28MASCOT%29%20was%20created%20at%20our%20institution%2C%20which%20comprised%20specialists%20from%20cardiology%2C%20pulmonology%2C%20hematology%2C%20interventional%20radiology%2C%20and%20cardiac%20surgery.%20MASCOT%20offers%20rapid%20consultation%2024%20hours%20a%20day%20with%20a%20web-based%20conference%20call%20to%20review%20patient%20data%20and%20discuss%20management%20of%20patients%20with%20high-risk%20PE.%20We%20reviewed%20patient%20data%20collected%20from%20MASCOT%26%23039%3Bs%20registry%20to%20analyze%20patient%20clinical%20characteristics%20and%20outcomes%20and%20describe%20the%20composition%20and%20operation%20of%20the%20team.%20Between%20August%202015%20and%20September%202016%2C%20MASCOT%20evaluated%2072%20patients.%20Seventy%20of%20the%2072%20patients%20were%20admitted%20to%20our%20institution%2C%20accounting%20for%2032%25%20of%20all%20patients%20discharged%20with%20a%20primary%20diagnosis%20of%20PE.%20Average%20age%20was%2062%5Cu2009%5Cu00b1%5Cu200917%20years%20with%20a%20female%20predominance%20%2863%25%29.%20Active%20malignancy%20%2831%25%29%2C%20recent%20surgery%20or%20trauma%20%2821%25%29%2C%20and%20recent%20hospitalization%20%2824%25%29%20were%20common.%20PE%20clinical%20severity%20was%20massive%20in%2016%25%20and%20submassive%20in%2083%25.%20Patients%20were%20managed%20with%20anticoagulation%20alone%20in%2065%25%20%28n%5Cu2009%3D%5Cu200946%29%2C%20systemic%20fibrinolysis%20in%2011%25%20%28n%5Cu2009%3D%5Cu20098%29%2C%20catheter-directed%20therapy%20in%2018%25%20%28n%5Cu2009%3D%5Cu200913%29%2C%20extracorporeal%20membrane%20oxygenation%20in%203%25%20%28n%5Cu2009%3D%5Cu20092%29%2C%20and%20an%20inferior%20vena%20cava%20filter%20was%20placed%20in%2015%25%20%28n%5Cu2009%3D%5Cu200911%29.%20Thirteen%20percent%20%28n%5Cu2009%3D%5Cu20099%29%20experienced%20a%20major%20bleed%20with%20no%20intracranial%20hemorrhage.%20Survival%20to%20discharge%20was%2089%25%20%2864%25%20with%20massive%20PE%20and%2093%25%20with%20submassive%20PE%29.%20In%20conclusion%2C%20multidisciplinary%2C%20rapid%20response%20PE%20teams%20offer%20a%20unique%20coordinated%20approach%20to%20patient%20care.%22%2C%22date%22%3A%222017-10-15%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.amjcard.2017.07.033%22%2C%22ISSN%22%3A%221879-1913%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22P39XB6TU%22%5D%2C%22dateModified%22%3A%222024-09-17T19%3A29%3A26Z%22%7D%7D%2C%7B%22key%22%3A%22K72ZPV8K%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Murphy%20et%20al.%22%2C%22parsedDate%22%3A%222014-05%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BMurphy%2C%20S.%20P.%2C%20Lee%2C%20R.%20J.%2C%20McClean%2C%20M.%20E.%20et%20al.%20%282014%29.%20MS-275%2C%20a%20class%20I%20histone%20deacetylase%20inhibitor%2C%20protects%20the%20p53-deficient%20mouse%20against%20ischemic%20injury.%20%26lt%3Bi%26gt%3BJ%20Neurochem%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B129%26lt%3B%5C%2Fi%26gt%3B%2C%20509%26%23x2013%3B515.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1111%5C%2Fjnc.12498%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1111%5C%2Fjnc.12498%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22MS-275%2C%20a%20class%20I%20histone%20deacetylase%20inhibitor%2C%20protects%20the%20p53-deficient%20mouse%20against%20ischemic%20injury%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sean%20P.%22%2C%22lastName%22%3A%22Murphy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rona%20J.%22%2C%22lastName%22%3A%22Lee%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Megan%20E.%22%2C%22lastName%22%3A%22McClean%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Heather%20E.%22%2C%22lastName%22%3A%22Pemberton%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Takuma%22%2C%22lastName%22%3A%22Uo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Richard%20S.%22%2C%22lastName%22%3A%22Morrison%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chinthasagar%22%2C%22lastName%22%3A%22Bastian%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Selva%22%2C%22lastName%22%3A%22Baltan%22%7D%5D%2C%22abstractNote%22%3A%22The%20administration%20of%20pan%20histone%20deacetylase%20%28HDAC%29%20inhibitors%20reduces%20ischemic%20damage%20to%20the%20CNS%2C%20both%20in%20vitro%20and%20in%20animal%20models%20of%20stroke%2C%20via%20mechanisms%20which%20we%20are%20beginning%20to%20understand.%20The%20acetylation%20of%20p53%20is%20regulated%20by%20Class%20I%20HDACs%20and%2C%20because%20p53%20appears%20to%20play%20a%20role%20in%20ischemic%20pathology%2C%20the%20purpose%20of%20this%20study%20was%20to%20discover%2C%20using%20an%20in%20vitro%20white%20matter%20ischemia%20model%20and%20an%20in%20vivo%20cerebral%20ischemia%20model%2C%20if%20neuroprotection%20mediated%20by%20HDAC%20inhibition%20depended%20on%20p53%20expression.%20Optic%20nerves%20were%20excised%20from%20wild-type%20and%20p53-deficient%20mice%2C%20and%20then%20subjected%20to%20oxygen-glucose%20deprivation%20in%20the%20presence%20and%20absence%20of%20a%20specific%20inhibitor%20of%20Class%20I%20HDACs%20%28MS-275%2C%20entinostat%29%20while%20compound%20action%20potentials%20were%20recorded.%20Furthermore%2C%20transient%20focal%20ischemia%20was%20imposed%20on%20wild-type%20and%20p53-deficient%20mice%2C%20which%20were%20subsequently%20treated%20with%20MS-275.%20Interestingly%2C%20and%20in%20both%20scenarios%2C%20the%20beneficial%20effects%20of%20MS-275%20were%20most%20pronounced%20when%20p53%20was%20absent.%20These%20results%20suggest%20that%20modulation%20of%20p53%20activity%20is%20not%20responsible%20for%20MS-275-mediated%20neuroprotection%2C%20and%20further%20illustrate%20how%20HDAC%20inhibitors%20variably%20influence%20p53%20and%20associated%20apoptotic%20pathways.%20Optic%20nerves%20from%20wild-type%20and%20p53-deficient%20mice%2C%20engineered%20to%20express%20cyan%20fluorescent%20protein%20%28CFP%29%20in%20neuronal%20mitochondria%2C%20were%20subjected%20to%20oxygen-glucose%20deprivation%20%28OGD%29%20in%20the%20presence%20and%20absence%20of%20a%20specific%20inhibitor%20of%20Class%20I%20histone%20deacetylases.%20The%20protective%20effect%20of%20MS-275%20was%20evidenced%20by%20mitochondrial%20preservation%2C%20and%20this%20was%20most%20pronounced%20in%20the%20absence%20of%20p53.%22%2C%22date%22%3A%222014-05%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1111%5C%2Fjnc.12498%22%2C%22ISSN%22%3A%221471-4159%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22P39XB6TU%22%5D%2C%22dateModified%22%3A%222024-09-17T19%3A29%3A59Z%22%7D%7D%5D%7D
Carroll, BJ, Pemberton, H., Bauer, KA et al. (2017). Inicio de un equipo multidisciplinario de respuesta rápida a la embolia pulmonar masiva y submasiva. Soy j cardiol 120, 1393-1398. https://doi.org/10.1016/j.amjcard.2017.07.033.
Murphy, SP, Lee, RJ, McClean, ME et al. (2014). MS-275, un inhibidor de la histona desacetilasa de clase I, protege al ratón deficiente en p53 contra la lesión isquémica. J Neurochem 129, 509-515. https://doi.org/10.1111/jnc.12498.

Noticias Recientes

Ver Todas

Celebrando a las mujeres en la ciencia en el Texas Heart Institute

Mientras el mundo celebra el Día Internacional de la Mujer y la Niña en la Ciencia, un día dedicado a reconocer la invaluable...

LEER MÁS

Mes del corazón 2025

Ha llegado febrero y se conmemora el Mes del Corazón en Estados Unidos. Es una excelente oportunidad para que la nación se una...

LEER MÁS

Defendiendo la salud de las mujeres: el Texas Heart Institute recibe a las defensoras de WomenHeart

El Texas Heart Institute (THI) ha sido durante mucho tiempo un defensor de la salud cardiovascular de las mujeres y ha dedicado más de una década a promover...

LEER MÁS
Fragmentos de código PHP Desarrollado por: XYZScripts.com